Cadence Pharmaceuticals Inc $14.01
|Trade Time:||Mar 07 08:10 PM Eastern Daylight Time|
|Change:||0.00 (0.00 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get CADX Trend Analysis - it has outperformed the S&P 500 by 143%
|Date||Name||Title||Volume||Trade Price||Holding Change|
|2/12/2014||DP VII ASSOCIATES LP||Substantial Shareholder||23,317||$7.84||57.60%|
|2/12/2014||DP VII ASSOCIATES LP||Substantial Shareholder||-13,058||$14.00||-20.47%|
|2/12/2014||DOMAIN PARTERS VII L P||Substantial Shareholder||-765,532||$14.00||-20.48%|
|2/12/2014||DOMAIN PARTERS VII L P||Substantial Shareholder||1,367,020||$7.84||57.65%|
|2/12/2014||FRAZIER ALAN D||Senior Executive Officer||173,792||$7.84||3.68%|
CADX Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!